Erlotinib is prescribed for:
- Non-small cell lung cancer with EGFR mutations
- Pancreatic cancer (with gemcitabine)
- Oncology targeted therapy
First-generation EGFR tyrosine kinase inhibitor.
Back to Medication Guide
Erlotinib
Generic Name: Erlotinib
Brand Names: Tarceva
Erlotinib is an EGFR inhibitor for non-small cell lung cancer and pancreatic cancer.
OncologyEGFR Inhibitor
What It's Used For
Side Effects
Common side effects:
- Rash (acneiform)
- Diarrhea
- Loss of appetite
- Fatigue
- Nausea
Serious side effects:
- Interstitial lung disease
- Hepatotoxicity
- GI perforation
- Severe skin reactions
Additional Information
What is Erlotinib?
Erlotinib is an EGFR inhibitor used for EGFR mutation-positive lung cancer.
EGFR Testing Required
EGFR mutation testing is required before starting - most effective in patients with activating EGFR mutations.
Take on Empty Stomach
Should be taken at least 1 hour before or 2 hours after food.
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Erlotinib? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.